108 related articles for article (PubMed ID: 25178327)
1. Serum and tumor microenvironment IL-8 values in different stages of colorectal cancer.
Bălăşoiu M; Bălăşoiu AT; Mogoantă SŞ; Bărbălan A; Stepan AE; Ciurea RN; Alexandru DO; Enescu A; Mogoantă L
Rom J Morphol Embryol; 2014; 55(2 Suppl):575-8. PubMed ID: 25178327
[TBL] [Abstract][Full Text] [Related]
2. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
[TBL] [Abstract][Full Text] [Related]
3. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
[TBL] [Abstract][Full Text] [Related]
4. [The levels of selected cytokines in patients with colorectal cancer--a preliminary report].
Grotowski M; Piechota W
Pol Merkur Lekarski; 2001 Oct; 11(64):327-9. PubMed ID: 11770312
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
6. [Role of IL-12P40 and IL-10 in progression of colorectal cancer].
Stanilov N; Miteva L; Stankova N; Jovchev J; Deliyski T; Stanilova S
Khirurgiia (Sofiia); 2010; (4-5):26-9. PubMed ID: 21972680
[TBL] [Abstract][Full Text] [Related]
7. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer.
Kim YW; Kim SK; Kim CS; Kim IY; Cho MY; Kim NK
Anticancer Res; 2014 Jul; 34(7):3481-7. PubMed ID: 24982357
[TBL] [Abstract][Full Text] [Related]
8. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production.
O'Hara RJ; Greenman J; MacDonald AW; Gaskell KM; Topping KP; Duthie GS; Kerin MJ; Lee PW; Monson JR
Clin Cancer Res; 1998 Aug; 4(8):1943-8. PubMed ID: 9717823
[TBL] [Abstract][Full Text] [Related]
9. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis.
Xia W; Chen W; Zhang Z; Wu D; Wu P; Chen Z; Li C; Huang J
PLoS One; 2015; 10(4):e0123484. PubMed ID: 25856316
[TBL] [Abstract][Full Text] [Related]
12. IL-6 and IL-8 responses of colorectal cancer in vivo and in vitro cancer cells subjected to simvastatin.
Malicki S; Winiarski M; Matlok M; Kostarczyk W; Guzdek A; Konturek PC
J Physiol Pharmacol; 2009 Dec; 60(4):141-6. PubMed ID: 20065508
[TBL] [Abstract][Full Text] [Related]
13. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
Ito H; Miki C
Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
[TBL] [Abstract][Full Text] [Related]
14. Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis.
Haraguchi M; Komuta K; Akashi A; Matsuzaki S; Furui J; Kanematsu T
Oncol Rep; 2002; 9(1):159-65. PubMed ID: 11748475
[TBL] [Abstract][Full Text] [Related]
15. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
[TBL] [Abstract][Full Text] [Related]
16. Histoprognostic markers role in colorectal cancer.
Bădulescu F; Mihai GM; Bădulescu A; Prejbeanu I
Rom J Morphol Embryol; 2016; 57(2):445-50. PubMed ID: 27516017
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of interleukin-23 associated with progression of colorectal cancer.
Hu WH; Chen HH; Yen SL; Huang HY; Hsiao CC; Chuang JH
J Surg Oncol; 2017 Feb; 115(2):208-212. PubMed ID: 27807862
[TBL] [Abstract][Full Text] [Related]
18. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
19. Targeting IL-8 in colorectal cancer.
Ning Y; Lenz HJ
Expert Opin Ther Targets; 2012 May; 16(5):491-7. PubMed ID: 22494524
[TBL] [Abstract][Full Text] [Related]
20. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
Han D; Wei Y; Wang X; Wang G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
